1 September 2024
Starpharma to present at US Drug Delivery Conference
Melbourne, Australia; Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced that it will be presenting its DEP™ platform at the 4th Annual Partnership Opportunities in Drug Delivery (PODD) conference in Boston this week.
PODD is attended by around 250 senior licensing and development executives from pharma and biotech with an interest in Drug Delivery. Speakers include industry experts from Roche, Amgen, Biogen Idec, Astra Zeneca, Boehringer Ingelheim, Janssen, Merck Serono, Novartis, Novo Nordisk Sanofi and Teva.
Starpharma’s presentation provides an overview of Starpharma’s DEP™ platform with a particular focus on the company’s recent work in targeted DEP™ conjugates including those which target the same HER-2 receptors as the highly successful cancer drug Herceptin.
View Presentation: Starpharma to present at US Drug Delivery Conference ( pdf file, 807kb)